I believe that the drag on performance over 20 - 30 years is a far greater risk
than currency fluctuation.
With the new portfolio especially, she's trying to let fundamentals rather
than currency fluctuations drive returns.
Not exact matches
(The company, which reports its financial results in euros, says
currency fluctuations make its recent sales and profit numbers look worse
than they are; it says its 2014 net sales of 14.8 billion euros were actually up 2 % from 2013.)
This is a far less volatile way of doing things
than using exchange rates: for example, the price of a hamburger doesn't jump 27 % simply because of
currency fluctuations.
Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, and capital markets conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) the Company's credit ratings and its cost of capital; (3) competitive conditions and customer preferences; (4) foreign
currency exchange rates and
fluctuations in those rates; (5) the timing and market acceptance of new product offerings; (6) the availability and cost of purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and other disasters and other events); (7) the impact of acquisitions, strategic alliances, divestitures, and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (8) generating fewer productivity improvements
than estimated; (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; and (11) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10 - K for the year ended Dec. 31, 2017, and any subsequent quarterly reports on Form 10 - Q (the «Reports»).
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger
than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued
fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause
fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause
fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions;
fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign
currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Because we hold significant assets and liabilities in
currencies other
than our Russian ruble operating
currency, and because foreign exchange
fluctuations are outside of our operational control, we believe that it is useful to present adjusted net income and related margin measures excluding these effects, in order to provide greater clarity regarding our operating performance.
Fluctuations in the exchange rates between the U.S. dollar and those other
currencies could result in the dollar equivalent of such expenses being higher and / or the dollar equivalent of such foreign - denominated revenue being lower
than would be the case if exchange rates were stable.
Foreign investments involve greater risks
than U.S. investments, including political and economic risks and the risk of
currency fluctuations, all of which may be magnified in emerging markets.
International markets entail different risks
than those typically associated with domestic markets, including foreign
currency fluctuation, political and economic instability, accounting changes and foreign taxation.
In the aftermath of the global financial crisis, broad changes in global investor risk sentiment were important drivers of
currency movements, at times driving more
than 50 percent of the
fluctuations, according to BlackRock analysis.
Investing in
currency involves additional special risks such as credit, interest rate
fluctuations, derivative investment risk, and domestic and foreign inflation rates, which can be volatile and may be less liquid
than other securities and more sensitive to the effect of varied economic conditions.
● Foreign investments may be more volatile and less liquid
than U.S. investments and are subject to the risk of
currency fluctuations and adverse political and economic developments.
Foreign investments involve greater risk
than US investments, including political and economic risks and the risk of
currency fluctuations.
Luxury sales advanced 6.3 percent, excluding acquisitions and
currency fluctuations, slightly faster
than the 6.2 percent median estimate compiled by Bloomberg.
However, inherent risks such as contingent liability (where your liability may be greater
than the initial purchase price of the investment), margining requirements (where you are required to make a series of payments against the purchase price, depending on whether the underlying investment or index is moving in your favour) and international exchanges (which can mean a reduced level of investor protection, as well as
currency fluctuation if the investment is not traded in sterling) meant these were out of reach.
Investments in
currency involve additional special risks, such as credit risk, interest rate
fluctuations, derivative investment risk which can be volatile and may be less liquid
than other securities and more sensitive to the effect of varied economic conditions.
More
than US$ 1.4 billion has flowed into exchange - traded funds that protect against
currency fluctuations in developing nations this year, 64 per cent more
than in all of 2014.
● Foreign investments may be more volatile and less liquid
than U.S. investments and are subject to the risk of
currency fluctuations and adverse political and economic developments.
While global equity funds can be volatile and involve more risk
than Canadian investments — depending on the state of world affairs,
currency fluctuations and other economic and political factors — they diversify against any type of country or political risk an investor might encounter.
International investing requires you to deal with
currency fluctuations, differing accounting procedures (that may make accurate evaluation more difficult), and foreign stock exchanges with different — usually more lax — regulations
than those we're accustomed to in this country.
Investments in
currency involve additional special risks, such as credit risk, interest rate
fluctuations, derivative investment risk which can be volatile and may be less liquid
than other securities and the effect of varied economic conditions.
And that's a number I can pretty much count on moving forward, other
than fluctuations with
currency affecting my foreign holdings (that tends to even out over the long haul).
• Due to its investment strategy, the fund may make higher capital gain distributions
than other ETFs Additional Risks for ROAM: Foreign investments may be more volatile and less liquid
than U.S. investments and are subject to the risk of
currency fluctuations and adverse political and economic developments.
Additional Risks for RODM: Foreign investments may be more volatile and less liquid
than U.S. investments and are subject to the risk of
currency fluctuations and adverse political and economic developments.
Among the potential dangers it cites: large
fluctuations in value, scamsters trying to capitalize on the hype surrounding these
currencies and higher costs
than you'll face with regular cash or credit cards.
I don't understand why gold preserves your wealth in the event of
currency fluctuations / collapse / hyperinflation better
than stocks or real estate?
In reality though, XSP lost 13.7 % in the 2006 - 2009 time period, which is more
than the loss experienced by a Canadian investor who directly invested in the S&P 500 and did not hedge the
currency fluctuations even though the US dollar depreciated 10.2 % that period.
Foreign securities may be subject to greater risks
than U.S. investments, including
currency fluctuations, less liquid trading markets, greater price volatility, political and economic instability, less publicly available information, and changes in tax or
currency laws or monetary policy.
If you own an investment in a country other
than Canada you are exposed to both the
fluctuations of the price of the asset in its home
currency, and the
fluctuations in the
currency that the asset is priced in.
Foreign investments involve greater risks
than U.S. investments, including political and economic risks and the risk of
currency fluctuations, all of which may be magnified in emerging markets.
Securities denominated in
currencies other
than U.S. dollars are subject to changes in value due to
fluctuation in exchange rates.
Foreign investments involve greater risks
than U.S. investments, including political and economic risks and the risk of
currency fluctuations.
Investing in foreign securities involves greater risks
than investing in securities of U.S. issuers, including
currency fluctuations, potential political instability, restrictions on foreign investors, less regulation and less market liquidity.
Haircuts applied to Permitted Cover and cross
currency haircuts (where collateral is posted in a
currency other
than that of the initial margin liability) are set to account for the risk associated with
fluctuations of collateral asset prices.
Unanticipated
fluctuations in
currency prices may result in a poorer overall performance for the fund
than if it had not engaged in any such transactions.
Unanticipated
fluctuations in
currency prices may result in a poorer overall performance for a fund
than if it had not engaged in any such transactions.
Hotel Name 1 will convert any Competing Price offered in a different
currency than the price made available through the Hotel Name 1 Website, and may deny claims where it determines that the difference between the price is due to exchange rate
fluctuations.
The cruise ship fuel surcharge is additional revenue to Viking Cruises, as are any additional charges relating to
currency fluctuation other
than for fully paid cruise fares and full fares, which
fluctuations are beyond our control.
Starwood will convert any Competing Rate offered in a different
currency than the rate made available through the Starwood Websites, and may deny claims where it determines that the difference between the rates is due to exchange rate
fluctuations.
Due to foreign
currency exchange
fluctuations, gift cards / certificates issued by Canadian retailers may be offered at a different redemption value
than gift cards / certificates issued by U.S. retailers and redemption values are subject to change without notice.
Because of
currency fluctuations, some people may end up paying slightly more for some software
than others.
But the prices achieved were far higher
than could be explained by
currency fluctuation,» he said.
There are few markets more complex
than forex, with some companies using artificial intelligence algorithms to foresee
currency exhange rate
fluctuations.